| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |